Elanco Animal Health (ELAN) Cash from Operations Growth (3y) (2020 - 2026)
Powered by 
Analysis
Elanco Animal Health (ELAN) Cash from Operations Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.46 Bn | 40.26 Bn | 779.09 Mn | 20.12% |
| 2 | Zoetis | 30.65 Bn | 28.98 Bn | 1.05 Bn | 52.97% |
| 3 | Elanco Animal Health | 11.82 Bn | 11.29 Bn | 798.00 Mn | 65.60% |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | 5.99% |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 75.29 Mn | 68.19 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -113.87% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 65.60% |
| Mar 31, 2026 | 27.85% |
| Dec 31, 2025 | 102.53% |
| Sep 30, 2025 | 5.03% |
| Jun 30, 2025 | -8.76% |
| Mar 31, 2025 | 59.89% |
| Dec 31, 2024 | -7.41% |
| Sep 30, 2024 | 22.10% |
| Jun 30, 2024 | 10.31% |
| Mar 31, 2024 | -55.04% |
| Dec 31, 2023 | 54.50% |
| Sep 30, 2023 | 55.61% |
| Jun 30, 2023 | -27.49% |
| Mar 31, 2023 | -236.93% |
| Dec 31, 2022 | -53.12% |
| Sep 30, 2022 | 68.37% |
| Jun 30, 2022 | 83.98% |
| Mar 31, 2022 | -112.93% |
| Dec 31, 2021 | 16.93% |
| Sep 30, 2021 | -18.42% |